失眠症
随机对照试验
睡眠开始
原发性失眠
焦虑
失眠的认知行为疗法
睡眠起始潜伏期
睡眠日记
睡眠障碍
认知行为疗法
物理疗法
认知疗法
心理学
医学
睡眠(系统调用)
唤醒
精神科
活动记录
内科学
操作系统
计算机科学
神经科学
作者
Mathilde I. Looman,Tessa F. Blanken,Tim M. Schoenmakers,Joyce E. Reesen,Marieke Effting,Floris E. Linnebank,Annemieke van Straten,Jan H. Kamphuis,Jaap Lancee
摘要
Introduction: Insomnia is common, but access to its first-line treatment, Cognitive Behavioral Therapy for Insomnia (CBT-I), is limited. To explore a scalable alternative, we investigated the efficacy of Sleep Restriction Therapy (SRT), a core component of CBT-I, delivered via telephone. Methods: In a randomized controlled trial, 147 adults with insomnia were allocated to 6 weeks of telephone-guided SRT (n = 76) or a sleep diary control group (n = 71). The SRT group received weekly supporting phone calls lasting 10 to 15 minutes. At baseline and post-test, we measured insomnia severity (primary outcome), sleep diary measures, anxiety symptoms, depressive symptoms, pre-sleep arousal, sleep-safety behaviors, daytime sleepiness, and dysfunctional sleep-related cognitions (secondary outcomes). The SRT group repeated these measures at 3- and 6-month follow-up. Results: Telephone-guided SRT showed large between-group effects on insomnia severity at post-test relative to the sleep diary control group (d = 1.52; p < .001). Based on intention-to-treat, 36 (47%) participants randomized to SRT achieved clinical improvement, and 23 (30%) achieved insomnia remission. We found medium-to-large between-group effects at post-test (d = 0.53 to 1.18) for all secondary outcomes except daytime sleepiness and total sleep time. At 3- and 6-month follow-up, the primary and all secondary outcomes, including daytime sleepiness and total sleep time, improved relative to baseline within the SRT group (d = 0.50 to 1.93). Conclusion: This trial shows that telephone-guided SRT is an effective insomnia treatment requiring minimal therapist guidance. If direct comparisons with CBT-I corroborate these findings, SRT could be an interesting scalable alternative to CBT-I as a first-line insomnia treatment. Trial registry: NCT05548907
科研通智能强力驱动
Strongly Powered by AbleSci AI